A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 33/00 (2006.01) A61K 31/445 (2006.01) A61K 31/495 (2006.01) A61K 31/54 (2006.01) A61K 31/55 (2006.01)
Patent
CA 2169247
The invention relates to pharmaceutical compounds for the treatment of patients which show symptoms of unspecified retarded maturity, such as Alzheimer's disease and other diseases which have an origin in numeric anomalies, deletions or chromosomatic fragility. These compounds include specific non-toxic quantities of, at least one of the follow- ing drugs: a) haloperidol (4-(4-(4-chlorophenol)-4-hydroxy piperidine)-1-(4-fluorophenol)-1-butanone; b) imipramine (10,11- dihydro-N,N-dimetil-5H-dibenz(b,f)-flazepine-5-propanamine; c) trifluoroperazine (10-(3-(4-methyl-1-piperazinil)-propil)-2- trifluoromethyl)-10H-phenotiazine; and also: d) gamma amino butyric acid; e) phenylalanine; f) anti-oxidizing agents, selected between ascorbic acid, vitamin E and mixtures of the same; g) folic acid; h) nicotinamide or pharmaceutical salts acceptable to the same, and i) lithium salts in combination with a pharmaceutically acceptable vehicle.
Bleiweiss Daniel Gustavo
Bleiweiss Eduardo Samuel
Bleiweiss Herman
Bleiweiss Daniel Gustavo
Bleiweiss Eduardo Samuel
Bleiweiss Herman
Smart & Biggar
LandOfFree
Pharmaceutical compositions and method for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions and method for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and method for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1765867